Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naive and antipsychotic-treated patients from India.
INTRODUCTION: In recent years, metabolic syndrome (MS) has been identified as an important health risk in patients with schizophrenia and related disorders, and has often been related to the use of second-generation antipsychotics. OBJECTIVE: The present ..... Read More